HAE Haemonetics Corporation Common Stock
Acerca de Haemonetics Corporation Common Stock Descripción general de la empresa de Wikipedia
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Leer más
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.
History
The company was founded in 1971. Haemonetics started out producing the containers and bags required for blood collection. The Latham Bowl was a disposable container that could automate the separation of blood by centrifugation. Through the 90's, the company added additional product lines and technologies. The company opened a manufacturing facility in Holbrook, Massachusetts in 1988.
In 1995 the company purchased the Intravenous Solutions manufacturing facility in Union, South Carolina.
Additional acquisitions grew the company and expanded its services. In the following years the company branched off to making the whole plasma collection station including the machine, supplies and software for plasma collection. These acquisitions included Edmonton-based Fifth Dimension (5D) Information Systems to gain entry into the blood and plasma software industry. Further acquisitions include Chicago-based Arryx in July 2006, Information Data Management, Inc. in January 2007, the acquisition of a division of Haemoscope in 2007, the acquisition of Infonale in July 2007, and, in 2009, Chico, California-based Altivation and Tucson, Arizona-based Sebra.
On August 21, 2007, 5D and IDM were officially merged into a new subsidiary called Haemonetics Software Solutions. The employees at both Edmonton (5D) and Rosemont (IDM) continue to work from their respective offices.
Further acquisitions included the April 2009 acquisition of Neoteric Technology Ltd and the April 2010 acquisition of California-based Global Med Technologies, Inc. Haemonetics acquired the Pall Corporation's transfusion medicine business on August 1, 2012 for ~$550 million.
In April 2024, it was announced Haemonetics had completed its acquisition of the Chicago-headquartered medical device temperature regulation manufacturer, Attune Medical for $160 million.
Product categories
Haemonetics products can be considered as belonging to two broad categories. Donor products (marketed to the blood donation industry, these include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit); and products that are marketed to the surgical suite for blood loss management for patients. These products include surgical blood salvage (or "autotransfusion") devices, surgical field blood suction systems, and blood and patient warming systems.
Hemostasis
TEG 5000
Kaolin TEG
Kaolin TEG with Heparinase
RapidTEG
TEG Functional Fibrinogen
TEG PlateletMapping
TEG 6S
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
HAE Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
HAE Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
HAE Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
- Compra fuerte 5 33,3%
- Compra 6 40,0%
- Mantener 4 26,7%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
10 analistas · 2026-08-13Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2027 | $1.14 | $1.09 | 0.05% |
| 30 de junio de 2026 | $1.14 | $1.09 | 0.05% |
| 31 de marzo de 2026 | $1.29 | $1.28 | 0.01% |
| 31 de diciembre de 2025 | $1.31 | $1.26 | 0.05% |
| 30 de septiembre de 2025 | $1.27 | $1.12 | 0.15% |
| 30 de junio de 2025 | $1.10 | $1.03 | 0.07% |
| 31 de marzo de 2025 | $1.24 | $1.23 | 0.01% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | — |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 16
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Cost of Revenue | $546M | $612M | $618M | $554M | $488M | $473M | $504M | $550M | $492M | $508M | $503M | $476M | |
| Gross Profit | $788M | $749M | $692M | $615M | $506M | $398M | $485M | $418M | $412M | $378M | $406M | $434M | |
| R&D Expense | $60M | $63M | $54M | $50M | $47M | $33M | $31M | $36M | $39M | $38M | $45M | $54M | |
| SG&A Expense | $442M | $437M | $430M | $377M | $340M | $275M | $282M | $273M | $317M | $302M | $317M | $337M | |
| Operating Expenses | $631M | $527M | $527M | $459M | $425M | $308M | $381M | $334M | $356M | $398M | $450M | $394M | |
| Operating Income | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M | |
| Other Non-op | $-29M | $-10M | $-13M | $-15M | $-17M | $-17M | $-16M | $-10M | $-5M | $-8M | $-9M | $-9M | |
| Pretax Income | $128M | $212M | $152M | $141M | $64M | $73M | $87M | $74M | $60M | $-27M | $-53M | $31M | |
| Income Tax | $31M | $44M | $34M | $26M | $20M | $-7M | $11M | $19M | $14M | $-1M | $2M | $14M | |
| Net Income | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| EPS (Basic) | $2.06 | $3.33 | $2.32 | $2.27 | $0.85 | $1.57 | $1.51 | $1.07 | $0.86 | $-0.51 | $-1.09 | $0.33 | |
| EPS (Diluted) | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 | $1.55 | $1.48 | $1.04 | $0.85 | $-0.51 | $-1.09 | $0.32 | |
| Shares (Basic) | 47,179,000 | 50,330,000 | 50,706,000 | 50,783,000 | 51,047,000 | 50,688,000 | 50,692,000 | 51,533,000 | 52,755,000 | 51,524,000 | 50,910,000 | 51,533,000 | |
| Shares (Diluted) | 47,354,000 | 50,730,000 | 51,397,000 | 51,420,000 | 51,353,000 | 51,292,000 | 51,815,000 | 52,942,000 | 53,501,000 | 51,524,000 | 50,910,000 | 52,089,000 | |
| EBITDA | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M |
Balance general 25
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $245M | $307M | $179M | $284M | $259M | $192M | $137M | $169M | $180M | $140M | $115M | $161M | |
| Receivables | $217M | $203M | $207M | $179M | $159M | $128M | $165M | $185M | $151M | $153M | $157M | $146M | |
| Inventory | $306M | $365M | $317M | $259M | $293M | $323M | $270M | $194M | $161M | $177M | $187M | $211M | |
| Prepaid Expense | $66M | $60M | $66M | $47M | $44M | $51M | $31M | $27M | $29M | $41M | $29M | $40M | |
| Current Assets | $835M | $935M | $769M | $770M | $756M | $694M | $604M | $576M | $521M | $510M | $488M | $558M | |
| PP&E (Net) | $306M | $284M | $311M | $311M | $258M | $218M | $253M | $344M | $332M | $324M | $338M | $322M | |
| PP&E (Gross) | $842M | $837M | $959M | $944M | $869M | $817M | $832M | $933M | $873M | $807M | $786M | $732M | |
| Accum. Depreciation | $536M | $553M | $648M | $633M | $611M | $600M | $579M | $589M | $541M | $484M | $449M | $410M | |
| Goodwill | $656M | $604M | $565M | $466M | $467M | $466M | $211M | $211M | $211M | $211M | $268M | $334M | |
| Intangibles | $448M | $456M | $406M | $276M | $310M | $365M | $133M | $128M | $157M | $178M | $204M | $245M | |
| Other Non-current Assets | $142M | $164M | $136M | $107M | $63M | $71M | $62M | $12M | $12M | $12M | $14M | $11M | |
| Total Assets | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Accounts Payable | $51M | $67M | $73M | $64M | $58M | $50M | $51M | $63M | $55M | $43M | $40M | $48M | |
| Current Liabilities | $283M | $578M | $300M | $252M | $442M | $253M | $275M | $236M | $385M | $211M | $186M | $189M | |
| Capital Leases | $41M | $50M | $58M | $56M | $56M | $63M | $52M | · | · | · | · | · | |
| Deferred Tax | $38M | $63M | $63M | $36M | $29M | $44M | $11M | $20M | $7M | $12M | $21M | $33M | |
| Other Non-current Liabilities | $59M | $68M | $75M | $75M | $80M | $100M | $89M | $29M | $34M | $22M | $26M | $32M | |
| Long-term Debt | $1.24B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $316M | $408M | $430M | |
| Total Debt | $1.22B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $315M | $408M | $428M | |
| Common Stock | $453.0K | $482.0K | $508.0K | $504.0K | $511.0K | $509.0K | $503.0K | $510.0K | $523.0K | $523.0K | $509.0K | $517.0K | |
| Retained Earnings | $279M | $352M | $360M | $253M | $202M | $158M | $79M | $161M | $267M | $290M | $316M | $420M | |
| AOCI | $-38M | $-55M | $-36M | $-30M | $-26M | $-30M | $-45M | $-30M | $-19M | $-33M | $-35M | $-22M | |
| Stockholders' Equity | $796M | $821M | $960M | $818M | $749M | $732M | $587M | $668M | $752M | $740M | $722M | $826M | |
| Liabilities + Equity | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Shares Outstanding | 45,252,667 | 48,215,899 | 50,787,859 | 50,448,519 | 51,124,240 | 50,868,820 | 50,322,930 | 51,019,918 | 52,342,965 | 52,255,495 | 50,932,348 | 51,670,969 |
Flujo de Efectivo 16
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $112M | $116M | $97M | $93M | $98M | $84M | $110M | $109M | $89M | $90M | $90M | $86M | |
| Stock-based Comp | $34M | $30M | $28M | $26M | $24M | $26M | $20M | $17M | $13M | $9M | $7M | $14M | |
| Deferred Tax | $-26M | $-6M | $-11M | $6M | $5M | $-21M | $-7M | $13M | $-6M | $-7M | $-1M | $4M | |
| Amort. of Intangibles | $50M | $56M | $41M | $42M | $57M | $41M | $34M | $25M | $32M | $37M | $59M | $34M | |
| Restructuring | $3M | $14M | $14M | $657.0K | $4M | $1M | $4M | $395.0K | $31M | $22M | $23M | $37M | |
| Operating Cash Flow | $293M | $182M | $182M | $273M | $172M | $109M | $158M | $159M | $220M | $160M | $122M | $127M | |
| CapEx | $33M | $39M | $38M | $191M | $97M | $37M | $49M | $119M | $75M | $76M | $102M | $122M | |
| Investing Cash Flow | $-180M | $-162M | $-322M | $-144M | $-86M | $-425M | $-57M | $-116M | $-63M | $-73M | $-105M | $-122M | |
| Debt Issued | · | · | · | · | · | · | $0 | $348M | $0 | $0 | · | $0 | |
| Net Debt Issued | · | $-5M | $-12M | $-10M | $-18M | $-22M | $-13M | $81M | $-62M | $-43M | $-21M | $-9M | |
| Stock Repurchased | $175M | $225M | $0 | $75M | $0 | $0 | $175M | $160M | $100M | $0 | $61M | $39M | |
| Net Stock Activity | $-175M | $-225M | $0 | $-75M | $0 | $0 | $-175M | $-160M | $-100M | $0 | $-61M | $-39M | |
| Financing Cash Flow | $-178M | $109M | $38M | $-100M | $-16M | $367M | $-131M | $-51M | $-121M | $-60M | $-63M | $-33M | |
| Net Change in Cash | $-61M | $128M | $-106M | $25M | $67M | $55M | $-32M | $-11M | $41M | $24M | $-46M | $-32M | |
| Taxes Paid | $61M | · | · | · | · | $12M | $12M | $8M | $9M | $7M | $8M | $11M | |
| Free Cash Flow | $260M | $142M | $115M | $163M | $76M | $72M | $109M | $40M | $146M | $84M | $19M | $5M |
Rentabilidad 8
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% | 45.7% | 49.0% | 43.1% | 45.6% | 42.7% | 44.7% | 47.7% | |
| Operating Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| Net Margin | 7.3% | 12.3% | 9.0% | 9.9% | 4.4% | 9.1% | 7.7% | 5.7% | 5.0% | -3.0% | -6.1% | 1.9% | |
| Pretax Margin | 9.6% | 15.6% | 11.6% | 12.1% | 6.4% | 8.4% | 8.8% | 7.6% | 6.6% | -3.1% | -5.9% | 3.4% | |
| EBITDA Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| ROA | 4.0% | 7.2% | 5.7% | 6.1% | 2.4% | 5.1% | 6.0% | 4.4% | 3.7% | -2.1% | -4.0% | 1.1% | |
| ROE | 11.8% | 19.4% | 12.3% | 14.5% | 5.9% | 11.0% | 13.2% | 8.7% | 6.1% | -3.6% | -7.2% | 2.0% | |
| ROIC | 5.9% | 8.6% | 7.2% | 8.0% | 3.6% | 6.8% | 9.4% | 6.1% | 4.3% | -1.8% | -4.0% | 1.8% |
Liquidez y Solvencia 4
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 | 2.7 | 2.2 | 2.4 | 1.4 | 2.4 | 2.6 | 3.0 | |
| Quick Ratio | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 | 1.3 | 1.1 | 1.5 | 0.9 | 1.4 | 1.5 | 1.6 | |
| Debt / Equity | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 | 1.0 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.5 | |
| LT Debt / Equity | 1.5 | 1.1 | 0.8 | 0.9 | 0.7 | 0.9 | 0.5 | 0.5 | 0.1 | 0.3 | 0.5 | 0.5 |
Eficiencia 3
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.8 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | |
| Inventory Turnover | 1.6 | 1.8 | 2.1 | 2.0 | 1.6 | 1.6 | 2.2 | 3.1 | 2.9 | 2.8 | 2.5 | 2.3 | |
| Receivables Turnover | 6.4 | 6.7 | 6.8 | 6.9 | 6.9 | 5.9 | 5.6 | 5.8 | 5.9 | 5.7 | 6.0 | 5.9 |
Tasas de Crecimiento 9
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.0% | 4.0% | 12.0% | 17.7% | 14.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 11.1% | 14.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -38.1% | 44.5% | 2.2% | 166.7% | -45.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -2.9% | 58.0% | 13.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 5.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -42.0% | 42.6% | 1.9% | 166.1% | -45.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -5.5% | 56.9% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.1% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Net Income TTM | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| Market Cap | $2.45B | $3.05B | $4.33B | $4.17B | $3.26B | $5.70B | $5.08B | $4.46B | $3.83B | $2.12B | $1.80B | $2.28B | |
| Enterprise Value | $3.42B | $3.96B | $4.96B | $4.66B | $3.78B | $6.21B | $5.33B | $4.64B | $3.90B | $2.30B | $2.09B | $2.55B | |
| P/E | 26.4 | 19.1 | 37.3 | 36.9 | 76.0 | 72.3 | 68.2 | 84.1 | 86.1 | -79.5 | -32.4 | 138.2 | |
| P/S | 1.8 | 2.2 | 3.3 | 3.6 | 3.3 | 6.5 | 5.1 | 4.6 | 4.2 | 2.4 | 2.0 | 2.5 | |
| P/B | 3.1 | 3.7 | 4.5 | 5.1 | 4.4 | 7.8 | 8.7 | 6.7 | 5.1 | 2.9 | 2.5 | 2.8 | |
| P / Tangible Book | · | · | · | 54.9 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 8.3 | 16.8 | 23.8 | 15.3 | 18.9 | 52.4 | 32.1 | 28.0 | 17.4 | 13.3 | 14.7 | 18.0 | |
| P / FCF | 9.4 | 21.4 | 37.5 | 25.6 | 43.1 | 79.4 | 46.4 | 110.7 | 26.3 | 25.4 | 92.4 | 460.7 | |
| EV / EBITDA | 21.8 | 17.9 | 30.1 | 29.8 | 46.8 | 69.2 | 51.5 | 55.6 | 69.5 | -118.4 | -47.6 | 62.9 | |
| EV / FCF | 13.1 | 27.8 | 43.0 | 28.6 | 49.9 | 86.6 | 48.7 | 115.2 | 26.8 | 27.5 | 107.4 | 514.6 | |
| EV / Revenue | 2.6 | 2.9 | 3.8 | 4.0 | 3.8 | 7.1 | 5.4 | 4.8 | 4.3 | 2.6 | 2.3 | 2.8 | |
| Earnings Yield | 3.8% | 5.2% | 2.7% | 2.7% | 1.3% | 1.4% | 1.5% | 1.2% | 1.2% | -1.3% | -3.1% | 0.72% |
Estado de resultados 16
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $339M | $346M | $339M | $327M | $321M | $331M | $349M | $346M | $336M | $343M | $336M | $318M | $340M | $305M | $297M | |
| Cost of Revenue | $137M | $148M | $137M | $133M | $129M | $138M | $155M | $158M | $161M | $167M | $158M | $148M | $169M | $147M | $140M | |
| Gross Profit | $203M | $198M | $202M | $195M | $192M | $193M | $194M | $187M | $175M | $176M | $178M | $171M | $172M | $159M | $158M | |
| R&D Expense | $16M | $14M | $14M | $15M | $16M | $18M | $16M | $14M | $14M | $16M | $13M | $13M | $16M | $13M | $11M | |
| SG&A Expense | $119M | $121M | $109M | $102M | $111M | $115M | $106M | $107M | $108M | $109M | $112M | $115M | $98M | $95M | $92M | |
| Operating Expenses | $145M | $221M | $135M | $136M | $138M | $122M | $135M | $136M | $135M | $146M | $132M | $135M | $121M | $115M | $111M | |
| Operating Income | $57M | $-23M | $67M | $58M | $54M | $71M | $59M | $52M | $40M | $30M | $46M | $35M | $51M | $43M | $47M | |
| Other Non-op | $-10M | $-5M | $-7M | $-7M | $-9M | $-598.0K | $-9M | $-7M | $7M | $-7M | $-2M | $-2M | $-3M | $-1M | $-6M | |
| Pretax Income | $48M | $-28M | $60M | $51M | $45M | $71M | $50M | $45M | $47M | $23M | $44M | $33M | $48M | $42M | $41M | |
| Income Tax | $15M | $-8M | $15M | $13M | $11M | $13M | $12M | $11M | $8M | $3M | $13M | $8M | $5M | $9M | $8M | |
| Net Income | $33M | $-20M | $45M | $39M | $34M | $58M | $37M | $34M | $38M | $20M | $31M | $25M | $42M | $33M | $33M | |
| EPS (Basic) | $0.73 | $-0.42 | $0.96 | $0.81 | $0.71 | $1.17 | $0.75 | $0.66 | $0.75 | $0.40 | $0.62 | $0.49 | $0.84 | $0.65 | $0.65 | |
| EPS (Diluted) | $0.72 | $-0.41 | $0.95 | $0.81 | $0.70 | $1.17 | $0.74 | $0.66 | $0.74 | $0.40 | $0.61 | $0.48 | $0.84 | $0.64 | $0.64 | |
| Shares (Basic) | 45,361,000 | -95,314,000 | 46,792,000 | 47,590,000 | 48,111,000 | -101,797,000 | 50,286,000 | 50,898,000 | 50,943,000 | 27,000 | 50,768,000 | 50,727,000 | -102,174,000 | 50,509,000 | 50,953,000 | |
| Shares (Diluted) | 45,704,000 | -95,650,000 | 46,987,000 | 47,664,000 | 48,353,000 | -102,713,000 | 50,639,000 | 51,240,000 | 51,564,000 | 3,000 | 51,445,000 | 51,396,000 | -103,165,000 | 51,219,000 | 51,558,000 | |
| EBITDA | $57M | · | $67M | $58M | $54M | · | $59M | $52M | $40M | · | $46M | $35M | · | $43M | $47M |
Balance general 25
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $223M | $245M | $363M | $296M | $293M | $307M | $321M | $299M | $344M | $179M | $194M | $351M | · | $224M | $241M | |
| Receivables | $216M | $217M | $196M | $207M | $201M | $203M | $212M | $214M | $201M | $207M | $212M | $174M | · | $181M | $172M | |
| Inventory | $307M | $306M | $321M | $336M | $361M | $365M | $360M | $382M | $374M | $317M | $304M | $286M | · | $256M | $255M | |
| Prepaid Expense | $65M | $66M | $63M | $60M | $59M | $60M | $113M | $61M | $59M | $66M | $55M | $55M | · | $45M | $48M | |
| Current Assets | $811M | $835M | $944M | $900M | $913M | $935M | $1.01B | $956M | $979M | $769M | $765M | $866M | · | $706M | $716M | |
| PP&E (Net) | $304M | $306M | $297M | $292M | $287M | $284M | $286M | $300M | $302M | $311M | $319M | $308M | · | $313M | $308M | |
| PP&E (Gross) | $854M | $842M | $837M | $815M | $795M | $837M | $867M | $939M | $949M | $959M | $979M | $950M | · | · | · | |
| Accum. Depreciation | $550M | $536M | $540M | $523M | $508M | $553M | $581M | $639M | $647M | $648M | $661M | $642M | · | · | · | |
| Goodwill | $657M | $656M | $607M | $606M | $607M | $604M | $605M | $616M | $613M | $565M | $555M | $465M | $466M | $466M | $465M | |
| Intangibles | $435M | $448M | $420M | $428M | $451M | $456M | $466M | $488M | $495M | $406M | $429M | $251M | · | $284M | $293M | |
| Other Non-current Assets | $150M | $142M | $216M | $208M | $196M | $164M | $160M | $156M | $142M | $136M | $127M | $117M | · | $103M | $80M | |
| Total Assets | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Accounts Payable | $56M | $51M | $49M | $62M | $46M | $67M | $63M | $69M | $77M | $73M | $57M | $80M | · | $64M | $61M | |
| Current Liabilities | $263M | $283M | $540M | $548M | $531M | $578M | $253M | $274M | $260M | $300M | $262M | $264M | · | $227M | $262M | |
| Capital Leases | · | $41M | · | · | · | $50M | · | · | · | $58M | · | · | · | · | · | |
| Deferred Tax | $39M | $38M | $56M | $58M | $59M | $63M | $61M | $63M | $65M | $63M | $62M | $35M | · | $40M | $36M | |
| Other Non-current Liabilities | $57M | $59M | $64M | $66M | $68M | $68M | $90M | $90M | $92M | $75M | $76M | $70M | · | $78M | $78M | |
| Long-term Debt | $1.19B | $1.24B | $1.22B | $1.22B | $1.22B | $1.25B | $1.22B | $1.22B | $1.22B | $808M | $871M | $762M | · | $767M | $818M | |
| Total Debt | $1.17B | · | $1.22B | $1.22B | $1.22B | · | $1.22B | $1.22B | $1.22B | · | $871M | $762M | · | $767M | $818M | |
| Common Stock | $455.0K | $453.0K | $468.0K | $467.0K | $482.0K | $482.0K | $502.0K | $504.0K | $512.0K | $508.0K | $508.0K | $507.0K | · | $504.0K | $506.0K | |
| Retained Earnings | $312M | $279M | $381M | $336M | $356M | $352M | $392M | $369M | $387M | $360M | $340M | $309M | · | $224M | $204M | |
| AOCI | $-42M | $-38M | $-35M | $-41M | $-36M | $-55M | $-56M | $-35M | $-43M | $-36M | $-24M | $-33M | · | $-36M | $-40M | |
| Stockholders' Equity | $837M | $796M | $911M | $849M | $882M | $821M | $907M | $879M | $905M | $960M | $943M | $894M | $818M | $776M | $729M | |
| Liabilities + Equity | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Shares Outstanding | 45,471,313 | 45,252,667 | 46,829,249 | 46,747,381 | 48,158,723 | 48,215,899 | 50,235,051 | 50,381,127 | 51,152,886 | 50,787,859 | 50,785,040 | 50,740,389 | · | 50,444,470 | 50,605,499 |
Flujo de Efectivo 13
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $27M | $27M | $27M | $28M | $29M | $28M | $29M | $29M | $29M | $28M | $24M | · | $24M | $24M | · | |
| Stock-based Comp | $9M | $9M | $8M | $8M | $9M | $7M | $8M | $7M | $8M | $7M | $7M | · | $7M | $7M | · | |
| Deferred Tax | $668.0K | $-20M | $-2M | $-725.0K | $-3M | $3M | $-2M | $-2M | $-4M | $-6M | $-3M | · | · | · | · | |
| Amort. of Intangibles | $12M | $12M | $12M | $13M | $13M | $13M | $14M | $14M | $14M | $13M | $9M | $9M | $15M | $10M | $11M | |
| Restructuring | $2M | $196.0K | $1M | $204.0K | $1M | $984.0K | $4M | $5M | $5M | $6M | $8M | $86.0K | $701.0K | $44.0K | $165.0K | |
| Operating Cash Flow | $52M | $71M | $94M | $111M | $17M | $117M | $44M | $49M | $-27M | $64M | $-540.0K | · | $80M | $64M | · | |
| CapEx | $8M | $18M | $6M | $5M | $4M | $16M | $9M | $9M | $6M | $7M | $-3M | · | $93M | $17M | · | |
| Investing Cash Flow | $-22M | $-87M | $-29M | $-30M | $-33M | $18M | $-17M | $-23M | $-139M | $-13M | $-269M | · | $-18M | $-36M | · | |
| Net Debt Issued | $-2M | · | · | · | $-2M | · | · | · | $-2M | · | · | · | · | · | · | |
| Stock Repurchased | · | $100M | $0 | · | · | $150M | $0 | · | · | $0 | $0 | · | $0 | $0 | · | |
| Financing Cash Flow | $-52M | $-101M | $2M | $-77M | $-2M | $-151M | $1M | $-75M | $334M | $-64M | $109M | · | $-2M | $-50M | · | |
| Net Change in Cash | $-22M | $-118M | $67M | $4M | $-14M | $-14M | $22M | $-45M | $166M | $-15M | $-157M | · | $60M | $-17M | · | |
| Free Cash Flow | $44M | · | · | · | $14M | · | · | · | $-33M | · | · | · | · | · | · |
Rentabilidad 8
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.8% | · | 59.7% | 59.5% | 59.8% | · | 55.5% | 54.2% | 52.0% | · | 52.9% | 53.6% | · | 52.0% | 53.1% | |
| Operating Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| Net Margin | 9.7% | · | 13.2% | 11.8% | 10.6% | · | 10.8% | 9.8% | 11.4% | · | 9.3% | 7.8% | · | 10.8% | 11.2% | |
| Pretax Margin | 14.0% | · | 17.7% | 15.7% | 14.1% | · | 14.3% | 12.9% | 13.9% | · | 13.1% | 10.3% | · | 13.8% | 13.8% | |
| EBITDA Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| ROA | 1.4% | · | 1.8% | 1.6% | 1.4% | · | 1.6% | 1.5% | 1.7% | · | 1.5% | 1.3% | · | 1.8% | 1.8% | |
| ROE | 3.8% | · | 4.9% | 4.5% | 3.8% | · | 4.0% | 3.8% | 4.3% | · | 3.6% | 3.1% | · | 4.4% | 4.7% | |
| ROIC | 2.0% | · | 2.4% | 2.1% | 1.9% | · | 2.1% | 1.9% | 1.5% | · | 1.8% | 1.6% | · | 2.2% | 2.4% |
Liquidez y Solvencia 4
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | 1.7 | 1.6 | 1.7 | · | 4.0 | 3.5 | 3.8 | · | 2.9 | 3.3 | · | 3.1 | 2.7 | |
| Quick Ratio | 1.7 | · | 1.0 | 0.9 | 0.9 | · | 2.1 | 1.9 | 2.1 | · | 1.5 | 2.0 | · | 1.8 | 1.6 | |
| Debt / Equity | 1.4 | · | 1.3 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 0.9 | 0.9 | · | 1.0 | 1.1 | |
| LT Debt / Equity | 1.4 | · | 1.0 | 1.1 | 1.0 | · | 1.3 | 1.4 | 1.3 | · | 0.9 | 0.8 | · | 1.0 | 1.0 |
Eficiencia 3
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.2 | 0.2 | · | 0.2 | 0.2 | |
| Inventory Turnover | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | · | 0.5 | 0.5 | |
| Receivables Turnover | 1.6 | · | 1.7 | 1.6 | 1.6 | · | 1.6 | 1.8 | 1.8 | · | 1.7 | 1.8 | · | 1.8 | 1.9 |
Valoración (TTM) 14
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | · | $1.34B | $1.34B | $1.35B | · | $1.37B | $1.34B | $1.30B | · | $1.27B | $1.23B | · | · | · | |
| Net Income TTM | $150M | · | $155M | $144M | $144M | · | $141M | $128M | $136M | · | $130M | $132M | · | · | · | |
| Market Cap | $3.51B | · | $3.76B | $2.25B | $3.55B | · | $3.90B | $4.02B | $4.23B | · | $4.34B | $4.55B | · | $3.97B | $3.75B | |
| Enterprise Value | $4.47B | · | $4.62B | $3.18B | $4.49B | · | $4.80B | $4.95B | $5.11B | · | $5.02B | $4.96B | · | $4.51B | $4.32B | |
| P/E | 24.3 | · | 25.1 | 16.6 | 26.0 | · | 28.2 | 32.0 | 31.5 | · | 33.8 | 35.0 | · | · | · | |
| P/S | 2.6 | · | 2.8 | 1.7 | 2.6 | · | 2.9 | 3.0 | 3.3 | · | 3.4 | 3.7 | · | · | · | |
| P/B | 4.2 | · | 4.1 | 2.7 | 4.0 | · | 4.3 | 4.6 | 4.7 | · | 4.6 | 5.1 | · | 5.1 | 5.1 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 25.6 | · | 155.7 | · | |
| P / Cash Flow | 67.2 | · | · | · | 204.3 | · | · | · | -154.3 | · | · | · | · | · | · | |
| P / FCF | 79.1 | · | · | · | 260.5 | · | · | · | -127.9 | · | · | · | · | · | · | |
| EV / EBITDA | 77.7 | · | 68.6 | 54.4 | 83.3 | · | 81.3 | 95.7 | 128.6 | · | 109.2 | 140.4 | · | 104.2 | 92.5 | |
| EV / FCF | 100.5 | · | · | · | 328.9 | · | · | · | -154.5 | · | · | · | · | · | · | |
| EV / Revenue | 3.4 | · | 3.5 | 2.4 | 3.3 | · | 3.5 | 3.7 | 3.9 | · | 3.9 | 4.0 | · | · | · | |
| Earnings Yield | 4.1% | · | 4.0% | 6.0% | 3.9% | · | 3.5% | 3.1% | 3.2% | · | 3.0% | 2.9% | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Ingresos | $1.33B | $1.36B | $1.31B | $1.17B | $993M |
| Margen Bruto % | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% |
| Margen Operativo % | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% |
| Beneficio neto | $97M | $168M | $118M | $115M | $43M |
| EPS Diluido | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 |
Balance general
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 |
| Ratio corriente | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 |
| Ratio Rápido | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 |
Flujo de Efectivo
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $260M | $142M | $115M | $163M | $76M |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 361 declarantes · $2.6B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 61 (+8 vs trimestre anterior) | 42 (-14 vs trimestre anterior) | 108 (-4 vs trimestre anterior) | 112 (-2 vs trimestre anterior) | +6.3M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $349 945 961 | 4 366 138 | 13,44% | Acciones |
| NEUBERGER BERMAN GROUP LLC | $308 172 249 | 4 108 761 | 11,84% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $190 979 550 | 2 546 394 | 7,34% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $154 468 350 | 2 059 578 | 5,93% | Acciones |
| STATE STREET CORP | $136 363 950 | 1 818 186 | 5,24% | Acciones |
| CITADEL ADVISORS LLC | $113 259 000 | 1 510 120 | 4,35% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $109 143 975 | 1 455 253 | 4,19% | Acciones |
| River Road Asset Management, LLC | $96 420 150 | 1 285 602 | 3,70% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $86 651 325 | 1 155 351 | 3,33% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $79 315 930 | 1 057 321 | 3,05% | Acciones |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $62 319 375 | 830 925 | 2,39% | Acciones |
| GOLDMAN SACHS GROUP INC | $52 644 150 | 701 922 | 2,02% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $44 356 725 | 591 423 | 1,70% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $42 780 975 | 570 413 | 1,64% | Acciones |
| Holocene Advisors, LP | $41 264 625 | 550 195 | 1,59% | Acciones |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $37 034 909 | 493 796 | 1,42% | Acciones |
| North Peak Capital Management, LLC | $25 730 775 | 343 077 | 0,99% | Acciones |
| LONDON CO OF VIRGINIA | $25 543 299 | 340 574 | 0,98% | Acciones |
| DEUTSCHE BANK AG\ | $25 282 575 | 337 101 | 0,97% | Acciones |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $24 905 625 | 332 075 | 0,96% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $24 779 850 | 330 398 | 0,95% | Acciones |
| Boston Trust Walden Corp | $24 170 475 | 322 273 | 0,93% | Acciones |
| Aristotle Capital Boston, LLC | $21 721 809 | 289 624 | 0,83% | Acciones |
| MIZUHO MARKETS AMERICAS LLC | $21 166 050 | 282 214 | 0,81% | Acciones |
| BANK OF AMERICA CORP /DE/ | $20 122 875 | 268 305 | 0,77% | Acciones |
| Invenomic Capital Management LP | $16 216 275 | 216 217 | 0,62% | Acciones |
| FMR LLC | $15 638 325 | 208 511 | 0,60% | Acciones |
| HEARTLAND ADVISORS INC | $15 000 000 | 200 000 | 0,58% | Acciones |
| GLENMEDE TRUST CO NA | $14 454 000 | 192 720 | 0,56% | Acciones |
| MORGAN STANLEY | $13 073 475 | 174 313 | 0,50% | Acciones |
| Longaeva Partners L.P. | $12 286 650 | 163 822 | 0,47% | Acciones |
| RHUMBLINE ADVISERS | $10 812 225 | 144 163 | 0,42% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $10 613 250 | 141 510 | 0,41% | Acciones |
| Balyasny Asset Management L.P. | $10 123 575 | 134 981 | 0,39% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $9 750 000 | 130 000 | 0,37% | Acciones |
| Point72 Asset Management, L.P. | $8 192 700 | 109 236 | 0,31% | Acciones |
| Verition Fund Management LLC | $7 913 100 | 105 508 | 0,30% | Acciones |
| ARIEL INVESTMENTS, LLC | $7 569 975 | 100 933 | 0,29% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $7 500 000 | 100 000 | 0,29% | Opción de compra |
| KESTREL INVESTMENT MANAGEMENT CORP | $7 305 000 | 97 400 | 0,28% | Acciones |
| Divisadero Street Capital Management, LP | $7 234 425 | 96 459 | 0,28% | Acciones |
| Swiss National Bank | $6 997 500 | 93 300 | 0,27% | Acciones |
| GOLDMAN SACHS GROUP INC | $6 750 000 | 90 000 | 0,26% | Opción de compra |
| GOLDMAN SACHS GROUP INC | $6 750 000 | 90 000 | 0,26% | Opción de venta |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6 510 000 | 86 800 | 0,25% | Opción de compra |
| Squarepoint Ops LLC | $6 459 300 | 86 124 | 0,25% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $6 215 025 | 82 867 | 0,24% | Acciones |
| Quantinno Capital Management LP | $5 477 550 | 73 034 | 0,21% | Acciones |
| ROYCE & ASSOCIATES LP | $5 360 625 | 71 475 | 0,21% | Acciones |
| AMERIPRISE FINANCIAL INC | $5 358 525 | 71 447 | 0,21% | Acciones |
| JUPITER ASSET MANAGEMENT LTD | $5 229 300 | 69 724 | 0,20% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $5 166 634 | 91 672 | 0,20% | Acciones |
| SEGALL BRYANT & HAMILL, LLC | $5 106 900 | 68 092 | 0,20% | Acciones |
| AMERICAN CAPITAL MANAGEMENT INC | $5 018 625 | 66 915 | 0,19% | Acciones |
| ISTHMUS PARTNERS, LLC | $4 946 325 | 65 951 | 0,19% | Acciones |
| Corient Private Wealth LP | $4 851 975 | 64 693 | 0,19% | Acciones |
| FIRST TRUST ADVISORS LP | $4 751 850 | 63 358 | 0,18% | Acciones |
| DEAN INVESTMENT ASSOCIATES, LLC | $4 649 175 | 61 989 | 0,18% | Acciones |
| PEREGRINE CAPITAL MANAGEMENT LLC | $4 497 450 | 59 966 | 0,17% | Acciones |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $4 484 325 | 59 791 | 0,17% | Acciones |
| Bridgewater Associates, LP | $4 479 975 | 59 733 | 0,17% | Acciones |
| ENVESTNET ASSET MANAGEMENT INC | $4 181 475 | 55 753 | 0,16% | Acciones |
| Trexquant Investment LP | $3 946 425 | 52 619 | 0,15% | Acciones |
| Aequim Alternative Investments LP | $3 840 000 | 51 200 | 0,15% | Acciones |
| RICE HALL JAMES & ASSOCIATES, LLC | $3 827 850 | 51 038 | 0,15% | Acciones |
| JANE STREET GROUP, LLC | $3 682 500 | 49 100 | 0,14% | Opción de compra |
| MetLife Investment Management, LLC | $3 681 075 | 49 081 | 0,14% | Acciones |
| BlackRock, Inc. | $3 618 975 | 48 253 | 0,14% | Acciones |
| Retirement Systems of Alabama | $3 604 875 | 48 065 | 0,14% | Acciones |
| Riverwater Partners LLC | $3 573 375 | 47 645 | 0,14% | Acciones |
| Skylands Capital, LLC | $3 571 875 | 47 625 | 0,14% | Acciones |
| FIFTH THIRD BANCORP | $3 561 472 | 47 486 | 0,14% | Acciones |
| ALGERT GLOBAL LLC | $3 522 750 | 46 970 | 0,14% | Acciones |
| STATE OF WISCONSIN INVESTMENT BOARD | $3 441 750 | 45 890 | 0,13% | Acciones |
| Qube Research & Technologies Ltd | $3 425 475 | 45 673 | 0,13% | Acciones |
| Dean Capital Management | $3 372 600 | 44 968 | 0,13% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $3 351 375 | 44 685 | 0,13% | Acciones |
| EASTERLY INVESTMENT PARTNERS LLC | $3 248 025 | 43 307 | 0,12% | Acciones |
| Phocas Financial Corp. | $3 227 250 | 43 030 | 0,12% | Acciones |
| ZB,N.A. | $3 200 968 | 40 996 | 0,12% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3 190 200 | 42 536 | 0,12% | Acciones |
| CONNORS INVESTOR SERVICES INC | $3 150 000 | 42 000 | 0,12% | Acciones |
| Expect Equity LLC | $3 076 950 | 41 026 | 0,12% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2 964 874 | 52 606 | 0,11% | Acciones |
| BEACON INVESTMENT ADVISORS LLC | $2 783 648 | 37 115 | 0,11% | Acciones |
| Campbell & CO Investment Adviser LLC | $2 763 300 | 36 844 | 0,11% | Acciones |
| Assenagon Asset Management S.A. | $2 633 175 | 35 109 | 0,10% | Acciones |
| BARCLAYS PLC | $2 448 300 | 32 644 | 0,09% | Acciones |
| MARSHALL WACE, LLP | $2 286 975 | 30 493 | 0,09% | Acciones |
| Cubist Systematic Strategies, LLC | $2 219 702 | 45 541 | 0,09% | Acciones |
| XTX Topco Ltd | $2 208 150 | 29 442 | 0,08% | Acciones |
| Legal & General Group Plc | $2 032 875 | 27 105 | 0,08% | Acciones |
| CARY STREET PARTNERS FINANCIAL LLC | $1 999 800 | 26 664 | 0,08% | Acciones |
| Nierenberg Investment Management Company, LLC | $1 971 000 | 26 280 | 0,08% | Acciones |
| Aurora Investment Counsel | $1 912 575 | 25 501 | 0,07% | Acciones |
| WESBANCO BANK INC | $1 912 500 | 25 500 | 0,07% | Acciones |
| Cardinal Capital Management | $1 861 275 | 24 817 | 0,07% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $1 846 275 | 24 617 | 0,07% | Acciones |
| Legato Capital Management LLC | $1 758 750 | 23 450 | 0,07% | Acciones |
| CITADEL ADVISORS LLC | $1 740 000 | 23 200 | 0,07% | Opción de compra |
Informantes de la empresa 72 insiders · 48 directivos · 25 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Christopher Simon, | President & CEO | 15 de mayo de 2026 A | 444 704 | 0 | 0 | $0 |
| Brian Concannon | President & CEO | 15 de septiembre de 2015 M | 147 040 | 0 | 0 | $0 |
| James Darecca | EVP, Chief Financial Officer | 15 de mayo de 2026 A | 54 444 | 0 | 0 | $0 |
| William P. Mr. Burke | EVP, Chief Financial Officer | 23 de agosto de 2021 M | 30 291 | 0 | 0 | $0 |
| Christopher J Lindop | CFO & EVP Business Development | 13 de enero de 2016 A | 56 743 | 0 | 0 | $0 |
| Ronald J Ryan | VP and CFO | 1 de noviembre de 2006 P | 2 101 | 0 | 0 | $0 |
| Stewart W Strong | President, Global Hospital | 26 de julio de 2024 S | 18 196 | 0 | 0 | $0 |
| Byron Selman | President, Global Markets | 25 de octubre de 2016 A | 23 318 | 0 | 0 | $0 |
| Peter M Allen | President, Global Plasma | 6 de julio de 2015 M | 34 102 | 0 | 0 | $0 |
| Kelly Michael P | President, Global Markets | 11 de noviembre de 2013 M | 10 987 | 0 | 0 | $0 |
| Mikael Gordon | President, Global Markets | 3 de mayo de 2012 M | 4 442 | 0 | 0 | $0 |
| Remi Corlin | President, Asia | 8 de agosto de 2008 M | 884 | 0 | 0 | $0 |
| Keiko Hattori | President, Haemonetics Japan | 1 de mayo de 2008 P | 716 | 0 | 0 | $0 |
| Thomas Lawlor | President, Patient Division | 28 de noviembre de 2007 M | 0 | 0 | 0 | $0 |
| Ryoji Sakai | President, Japan | 14 de junio de 2007 M | 0 | 0 | 0 | $0 |
| Ulrich Eckert | President, Europe & Latin Am | 1 de noviembre de 2006 P | 890 | 0 | 0 | $0 |
| Yutaka Sakurada | President, Japan & Asia | 2 de mayo de 2005 P | 2 347 | 0 | 0 | $0 |
| Frank Chan | EVP, Chief Operating Officer | 15 de mayo de 2026 A | 32 936 | 0 | 0 | $0 |
| Kent J Davies | Chief Operating Officer | 23 de octubre de 2015 S | 16 891 | 0 | 0 | $0 |
| Farris Maryanne Maunsell | VP, Chief Accounting Officer | 5 de junio de 2026 F | 6 242 | 0 | 0 | $0 |
| Laurie A. Miller | SVP, Human Resources | 5 de junio de 2026 F | 40 987 | 0 | 0 | $0 |
| Roy Galvin | EVP, Chief Commercial Officer | 15 de mayo de 2026 A | 39 882 | 0 | 0 | $0 |
| Michelle L Basil | EVP and General Counsel | 15 de mayo de 2026 A | 68 829 | 0 | 0 | $0 |
| Anila Lingamneni | EVP, Chief Technology Officer | 12 de julio de 2024 S | 21 331 | 0 | 0 | $0 |
| Josep Llorens | EVP, Global Manufacturing | 28 de mayo de 2024 F | 30 940 | 0 | 0 | $0 |
| Dan Goldstein | VP, Corporate Controller | 13 de junio de 2022 S | 4 447 | 0 | 0 | $0 |
| Jacqueline Scanlan | SVP, Global Human Resources | 7 de junio de 2021 S | 4 216 | 0 | 0 | $0 |
| Said Bolorforosh | EVP, Chief Technology Officer | 11 de noviembre de 2019 S | 1 977 | 0 | 0 | $0 |
| Neil 122-62-507 Ryding | EVP, Global Manufacturing | 7 de junio de 2018 S | 15 226 | 0 | 0 | $0 |
| David Fusco | EVP, Global Human Resources | 25 de octubre de 2016 A | 16 867 | 0 | 0 | $0 |
| Sandra Jesse | EVP and Chief Legal Officer | 25 de octubre de 2016 A | 48 166 | 0 | 0 | $0 |
| Jonathan White | Chief Science and Technology | 26 de octubre de 2015 S | 30 507 | 0 | 0 | $0 |
| Susan M Hanlon | VP Finance | 26 de octubre de 2015 S | 20 464 | 0 | 0 | $0 |
| Brian R Burns | EVP, Global QA/RA | 23 de octubre de 2015 S | 16 235 | 0 | 0 | $0 |
| Dave Helsel | EVP, Global Manufacturing | 13 de abril de 2015 D | 13 216 | 0 | 0 | $0 |
| Kathleen Mcdaniel | EVP Global Human Resources | 28 de agosto de 2014 S | 5 013 | 0 | 0 | $0 |
| Warren Nighan JR | EVP, Global QA/RA | 24 de julio de 2013 A | 7 618 | 0 | 0 | $0 |
| Joseph J Forish | VP, Human Resources | 30 de abril de 2013 P | 17 279 | 0 | 0 | $0 |
| Phillip John Brancazio | VP, Global Manufacturing | 4 de mayo de 2011 P | 3 052 | 0 | 0 | $0 |
| Alicia R Lopez | VP, Corporate Affairs | 5 de abril de 2011 D | 2 815 | 0 | 0 | $0 |
| Michael I Ruxin | VP Global Software Strategies | 4 de noviembre de 2010 P | 215 | 0 | 0 | $0 |
| Brad Nutter | Chairman of the Board | 29 de julio de 2010 A | 10 580 | 0 | 0 | $0 |
| Robert B Ebbeling | Vice President, Operations | 1 de mayo de 2009 P | 15 849 | 0 | 0 | $0 |
| Jan Conneely | VP & GM, Arryx, Inc. | 1 de mayo de 2008 P | 1 041 | 0 | 0 | $0 |
| William Granville | VP, Manufacturing | 1 de mayo de 2008 P | 12 188 | 0 | 0 | $0 |
| Mark A Popovsky | VP, Corporate Medical Director | 1 de mayo de 2008 P | 4 891 | 0 | 0 | $0 |
| Stephen Swenson | VP & General Mgr, Global Plasm | 1 de mayo de 2008 P | 3 024 | 0 | 0 | $0 |
| William Roche Still | VP & Gen Mrg, Therapeutics Bus | 4 de mayo de 2007 M | 4 193 | 0 | 0 | $0 |
| Lloyd Emerson Johnson | Consejero | 24 de julio de 2026 A | 15 471 | 0 | 0 | $0 |
| Diane M Bryant | Consejero | 24 de julio de 2026 A | 9 664 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 8 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 6 de febrero de 2004 | — | Presentación inicial | — | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 20 de agosto de 2003 | — | Presentación inicial | — | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 8 de agosto de 2003 | — | Presentación inicial | — | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 24 de junio de 2003 | — | Presentación inicial | — | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 19 de junio de 2003 | — | Presentación inicial | — | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 3 de junio de 2003 | — | Presentación inicial | — | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 27 de mayo de 2003 | — | Presentación inicial | — | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 15 de junio de 2001 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 87 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| NBSM · Neuberger Berman ETF Trust | 1,86% | 61 981 NS | 31 de mayo de 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,84% | 43 927 NS | 30 de abril de 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,77% | 125 093 NS | 30 de abril de 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,64% | 5 836 NS | 30 de abril de 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,46% | 12 701 NS | 31 de mayo de 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,35% | 201 070 NS | 30 de abril de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,32% | 35 814 NS | 31 de mayo de 2026 | N-PORT |
| ABCS · EA Series Trust | 0,31% | 522 NS | 29 de mayo de 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,24% | 41 437 NS | 30 de abril de 2026 | N-PORT |
| IWO · iShares Trust | 0,23% | 402 938 SH | 8 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,23% | 75 831 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,20% | 47 624 SH | 8 de agosto de 2026 | Diario |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,19% | 76 694 NS | 31 de mayo de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 17 393 NS | 30 de abril de 2026 | N-PORT |
| MIDE · DBX ETF Trust | 0,13% | 63 NS | 29 de mayo de 2026 | N-PORT |
| IJK · iShares Trust | 0,13% | 163 140 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,13% | 1 201 903 SH | 8 de agosto de 2026 | Diario |
| BKSE · BNY Mellon ETF Trust | 0,13% | 1 703 NS | 30 de abril de 2026 | N-PORT |
| XJH · iShares Trust | 0,12% | 6 299 SH | 8 de agosto de 2026 | Diario |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 12 097 NS | 30 de abril de 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,12% | 24 558 SH | 8 de agosto de 2026 | Diario |
| SMDX · Tidal Trust III | 0,12% | 2 419 NS | 30 de abril de 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,11% | 27 512 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,11% | 271 486 SH | 8 de agosto de 2026 | Diario |
| NUSC · Nushares ETF Trust | 0,11% | 23 551 NS | 30 de abril de 2026 | N-PORT |
| IJH · iShares Trust | 0,11% | 1 603 400 SH | 8 de agosto de 2026 | Diario |
| FSMD · FIDELITY COVINGTON TRUST | 0,11% | 42 163 NS | 30 de abril de 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,11% | 5 312 SH | 8 de agosto de 2026 | Diario |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,10% | 74 976 SH | 8 de agosto de 2026 | Diario |
| FNDA · SCHWAB STRATEGIC TRUST | 0,10% | 126 817 NS | 31 de mayo de 2026 | N-PORT |
| IJJ · iShares Trust | 0,09% | 94 775 SH | 8 de agosto de 2026 | Diario |
| EBIT · Harbor ETF Trust | 0,09% | 168 NS | 30 de abril de 2026 | N-PORT |
| ESML · iShares Trust | 0,09% | 29 374 SH | 8 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,09% | 20 324 NS | 30 de abril de 2026 | N-PORT |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,08% | 15 968 SH | 8 de agosto de 2026 | Diario |
| ITWO · ProShares Trust | 0,08% | 2 210 NS | 31 de mayo de 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,08% | 5 212 NS | 30 de abril de 2026 | N-PORT |
| ISCV · iShares Trust | 0,07% | 6 131 SH | 8 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,07% | 159 737 NS | 30 de abril de 2026 | N-PORT |
| MVV · ProShares Trust | 0,07% | 1 606 NS | 31 de mayo de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,07% | 222 776 NS | 31 de mayo de 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,06% | 12 283 NS | 30 de abril de 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,06% | 9 034 SH | 8 de agosto de 2026 | Diario |
| ISCB · iShares Trust | 0,06% | 1 979 SH | 8 de agosto de 2026 | Diario |
| SMLF · iShares Trust | 0,06% | 28 701 SH | 8 de agosto de 2026 | Diario |
| MIDU · Direxion Shares ETF Trust | 0,06% | 770 NS | 30 de abril de 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,05% | 2 220 NS | 31 de mayo de 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,05% | 1 979 NS | 31 de mayo de 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,05% | 302 003 SH | 8 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,05% | 139 826 SH | 8 de agosto de 2026 | Diario |